Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lung cancer
Pharma
Summit stock falls as Akeso shares bispecific OS data vs. Keytruda
Summit’s stock price plummeted by nearly 37% following Akeso’s overall survival reveal before a trading halt was initiated.
Angus Liu
Apr 25, 2025 4:02pm
Akeso's fast-rising ivonescimab scores 3rd lung cancer trial win
Apr 23, 2025 11:30am
AZ, Daiichi kick off busy 2025 with FDA nod for their 2nd ADC
Jan 17, 2025 9:14pm
Anyone with lungs can get cancer, warns new campaign
Oct 23, 2024 12:46pm
American Lung Association aims to ‘BEAT’ cancer in new campaign
Jul 16, 2024 1:46pm
Janssen, Roche lead reputation rankings in common cancers
Jun 21, 2024 10:59am